메뉴 건너뛰기




Volumn 27, Issue 16, 2009, Pages 2195-2198

Vaccination against the Human Papillomavirus: The lessons we have not learned

Author keywords

Hepatitis B; Human Papillomavirus; Vaccine

Indexed keywords

HEPATITIS B VACCINE; WART VIRUS VACCINE;

EID: 61849126865     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.016     Document Type: Editorial
Times cited : (4)

References (14)
  • 1
    • 39149104081 scopus 로고    scopus 로고
    • Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States
    • Chaturvedi A.K., Engels E.A., Anderson W.F., and Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. Journal of Clinical Oncology 26 4 (2008) 612-619
    • (2008) Journal of Clinical Oncology , vol.26 , Issue.4 , pp. 612-619
    • Chaturvedi, A.K.1    Engels, E.A.2    Anderson, W.F.3    Gillison, M.L.4
  • 2
    • 27644553811 scopus 로고    scopus 로고
    • Experience with hepatitis A and B vaccines
    • Davis J.P. Experience with hepatitis A and B vaccines. American Journal of Medicine 118 Suppl. 10A (2005) 7S-15S
    • (2005) American Journal of Medicine , vol.118 , Issue.SUPPL. 10A
    • Davis, J.P.1
  • 3
    • 33846102585 scopus 로고    scopus 로고
    • Model for assessing human papillomavirus vaccination strategies
    • Elbasha E.H., Dasbach E.J., and Insinga R.P. Model for assessing human papillomavirus vaccination strategies. Emerging Infectious Diseases 13 1 (2007) 28-41
    • (2007) Emerging Infectious Diseases , vol.13 , Issue.1 , pp. 28-41
    • Elbasha, E.H.1    Dasbach, E.J.2    Insinga, R.P.3
  • 4
    • 32944478843 scopus 로고    scopus 로고
    • The coming storm over a cancer vaccine
    • Guyon J. The coming storm over a cancer vaccine. Fortune 152 9 (2005) 123-124
    • (2005) Fortune , vol.152 , Issue.9 , pp. 123-124
    • Guyon, J.1
  • 5
    • 2342644800 scopus 로고    scopus 로고
    • Why we're losing the war on cancer (and how to win it)
    • Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 149 6 (2004) 76-82
    • (2004) Fortune , vol.149 , Issue.6 , pp. 76-82
    • Leaf, C.1
  • 6
    • 36248935547 scopus 로고    scopus 로고
    • HPV vaccination and the prevention of cervical cancer: the long road ahead
    • Markman M. HPV vaccination and the prevention of cervical cancer: the long road ahead. Journal of Women's Health 16 9 (2007) 1366-1367
    • (2007) Journal of Women's Health , vol.16 , Issue.9 , pp. 1366-1367
    • Markman, M.1
  • 7
    • 33748761925 scopus 로고    scopus 로고
    • The burden of HPV-related cancers
    • Chapter 2
    • Parkin D.M., and Bray F. The burden of HPV-related cancers. Vaccine 24 Suppl. 3 (2006) S11 Chapter 2
    • (2006) Vaccine , vol.24 , Issue.SUPPL. 3
    • Parkin, D.M.1    Bray, F.2
  • 8
    • 34247592039 scopus 로고    scopus 로고
    • Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer
    • Stanley M. Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer. British Journal of Cancer 96 9 (2007) 1320-1323
    • (2007) British Journal of Cancer , vol.96 , Issue.9 , pp. 1320-1323
    • Stanley, M.1
  • 9
    • 0036310868 scopus 로고    scopus 로고
    • The case for comprehensive sex education
    • Starkman N., and Rajani N. The case for comprehensive sex education. AIDS Patient Care & STDs 16 7 (2002) 313
    • (2002) AIDS Patient Care & STDs , vol.16 , Issue.7 , pp. 313
    • Starkman, N.1    Rajani, N.2
  • 10
    • 38849146414 scopus 로고    scopus 로고
    • Human papillomavirus-related content in state and tribal comprehensive cancer control plans
    • Steele B.C., Thomas C.N., Richardson C., and Richardson L.C. Human papillomavirus-related content in state and tribal comprehensive cancer control plans. Journal of Women's Health 16 1 (2008) 5
    • (2008) Journal of Women's Health , vol.16 , Issue.1 , pp. 5
    • Steele, B.C.1    Thomas, C.N.2    Richardson, C.3    Richardson, L.C.4
  • 11
    • 0023759932 scopus 로고
    • Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness
    • Stephenne J. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness. Vaccine 6 4 (1988) 299-303
    • (1988) Vaccine , vol.6 , Issue.4 , pp. 299-303
    • Stephenne, J.1
  • 12
    • 34648825016 scopus 로고    scopus 로고
    • Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?
    • Sturgis E.M., and Cinciripini P.M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer 110 7 (2007) 1429-1435
    • (2007) Cancer , vol.110 , Issue.7 , pp. 1429-1435
    • Sturgis, E.M.1    Cinciripini, P.M.2
  • 13
    • 1842736011 scopus 로고    scopus 로고
    • Recombivax-HB: perspectives past, present and future
    • Venters C., Graham W., and Cassidy W. Recombivax-HB: perspectives past, present and future. Expert Review of Vaccines 3 2 (2004) 119-129
    • (2004) Expert Review of Vaccines , vol.3 , Issue.2 , pp. 119-129
    • Venters, C.1    Graham, W.2    Cassidy, W.3
  • 14
    • 36248951595 scopus 로고    scopus 로고
    • Moving forward: human papillomavirus vaccination and the prevention of cervical cancer
    • Vetter K.M., and Geller S.E. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer. Journal of Women's Health 16 9 (2007) 1258-1268
    • (2007) Journal of Women's Health , vol.16 , Issue.9 , pp. 1258-1268
    • Vetter, K.M.1    Geller, S.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.